1[1]Arbyn M,Buntinx F,Van Ranst M,et al.Virologic versus cytologic triage of women with equivocal Pap smears:a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia[J].J Nail Cancer Inst,2004,96:280-293.
2[2]Cox T,Cuzick J.HPV DNA testing in cervical cancer screening:From evidence to policies[J].Gynecol Onco1,2006,103:8-11.
3[3]Ronco G,Segnan N,Giorgi-Rossi P,et al.And the NTCC working group,human papillomavirus testing and liquid-based cytology in primary cervical screening:results at recruitment from the NTCC randomized controlled trial[J].J Natl Cancer Inst,2006,98:765-774.
4[4]Solomon D,Shiffman M,Tarone R,et al.Comparison of three management strategies for patients with atypical squamous cells of undetermined significance:baseline results from a randomised trial[J].J Natl Cancer Inst,2001,93:293-299.
5[5]Walker JL,Wang SS,Schiffman M,et al.Predicting absolute risk of CIN3 during post-colposcopic follow-up:results from the ASCUS-LSIL Triage Study (ALTS)[J].Am J Obstet Gynecol,2006,195(2)341-348.
6[6]American College of Obstetricians and Gynecologists.ACOG Practice bulletin.Cervical Cytology Screening.Humber 45,August 2003[J].Int J Gyneacol Obstet,2003,83 (2):237-247.
7[7]Management of abnormal cervical cytology and histology.Clinical management guidelines for the obstetrician and gynecologist[R].ACOG Practice Bulletin,2005 (August):vol 66.
8[8]IARC.Handbooks of cancer prevention.Cervix cancer screening[R].Lyon:IARC Press,2005.
9[9]Wright Jr TC,Cox JT,Massad IS,et al.Consensus guidelines for the management of women with cervical cytological abnormalities 2001[J].JAMA,2002,287:2120-2129.
10[10]Wright TC Jr,Schiffman M,Solomon D,et al.Interim guidance for the use of human papillomaviras DNA testing as an adjunct to cervical cytology for screening[J].Obstet Gynecol,2004,103:304-309.
6Cox J T.Human papillomavirus testing in primary cervical screening and abnormal papanicolaon management[J].Obstet Gynecol Sun,2006,61(6):15-25.
7Honfflin Debarge V,Vinatier D,et al.Value of human papillomavirus testing after conization by loop electrosurgical excision for high grade squamous intraepithelial lesions[J].Gynecol Oncol,2003,90(3):587-592.
8de Sanjos é S,Diaz M,Castellsagu é X,et al.World-wide prevalence and genotype distribution of cervicalhuman papil-loma virus DNA in women with normal cytology:a meta analysis[J].J Lancet Infect Dis,2007,7(7):453-459.
9Ronco G, Segnan N, Giorgi-Rossi P, et al. Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial [ J ]. J Natl Cancer Inst,2006,98 ( 11 ) : 765- 774.
10Mayrand MH, Duarte-Franco E, Rodrigues I, et al. Human papllo- mavirus DNA versus papanicolaou screening tests for cervical cancer [J]. N Engl J Med,2007,357(16) :1579-1588.
